POLYCYSTIC OVARY SYNDROME AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS IN DUHOK CITY, KURDISTAN REGION OF IRAQ
Abstract
https://doi.org/10.31386/dmj.2024.18.2.6
Background: PCOS is the most common endocrine disorders with a potential to cause short- and long-term comorbidities especially T2DM. The present study was conducted to determine the prevalence of PCOS among type 2 diabetic patients in Duhok City, Kurdistan Region of Iraq.
Methods: This study is an observational study conducted through cross-sectional design. Type 2 diabetic women (n = 200) at reproductive age were included. PCOS was confirmed using the clinical, hormonal and radiological findings according to Rotterdam criteria. Data of the study are determined in frequency distribution whether mean and standard deviation or frequency and percentage.
Results: The prevalence of PCOS was high (81.5%) among type 2 diabetic women. The frequency of clinical findings in the type 2 diabetic patients revealed that majority of them had clinical feature and hormonal features while 77% of them had positive ultrasound features, 49% were newly diagnosed diabetic patients and 44.5% of the patients on metformin medication.
Conclusions: PCOS is highly prevalent in type 2 diabetic patients. In-depth research is required to determine the appropriate methods to identify susceptible women including genetic studies in order to prevent or treat or limit the implications.
Downloads
References
2-Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P T. 2013 Jun;38(6):336-55. PMID: 23946629; PMCID: PMC3737989.
3-Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. (2022). Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review. World J Diabetes 2022; 13(1): 5-26 [PMID: 35070056 DOI: 10.4239/wjd.v13.i1.5]
4-Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. (2006). Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006 Nov;91(11):4237-45. doi: 10.1210/jc.2006-0178. Epub 2006 Aug 29. PMID: 16940456.
5-CDC (Centers for Disease Control and Prevention) (2022). PCOS (Polycystic Ovary Syndrome) and Diabetes. https://www.cdc.gov/nchs/. July 3rd, 2023.
6-Dybciak P, Humeniuk E, Raczkiewicz D, Krakowiak J, Wdowiak A, Bojar I. (2022). Anxiety and Depression in Women with Polycystic Ovary Syndrome. Medicina (Kaunas). 2022 Jul 16;58(7):942. doi: 10.3390/medicina58070942. PMID: 35888661; PMCID: PMC9319705.
7-Chang S, Dunaif A. (2021). Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When? Endocrinol Metab Clin North Am. 2021 Mar;50(1):11-23. doi: 10.1016/j.ecl.2020.10.002. PMID: 33518179; PMCID: PMC7860982.
8-NHS (National Health Service) (2022). Overview-Polycystic ovary syndrome. https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/.
9-Briden L. (2018). The link between PCOS and insulin resistance. https://helloclue.com/articles/cycle-a-z/the-link-between-pcos-and-insulin-resistance
10-Ollila ME, West S, Keinanen-Kiukaanniemi S, Jokelainen J, Auvinen J, Puukka K, et al . (2017). Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population- based cohort study. Hum Reprod .2017; 32: 423–431.
11-Abdulah DM., Hassan AB., Saadi FS., Mohammed AH. (2018). Impacts of self-management education on glycaemic control in patients with type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Volume 12, Issue 6, 2018, Pages 969-975, ISSN 1871-4021, https://doi.org/10.1016/j.dsx.2018.06.007. (https://www.sciencedirect.com/science/article/pii/S187140211830214).
12-Hassan, AB. , Salih, SF., Hassan, II. , Saadi, FS., Abdulah, DM., Ahmed IH., Taher SM., Khaleel BB. (2019). Circulating betatrophin in relation to metabolic, inflammatory parameters, and oxidative stress in patients with type 2 diabetes mellitus, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 13, Issue 1, 2019, Pages 458-463, ISSN 1871-4021, https://doi.org/10.1016/j.dsx.2018.11.016.
13-Rajab HA, Hassan AB, Hassan II, Abdulah DM, Saadi FS. (2020). Circulating human anti nucleolus antibody (ANCAb) and biochemical parameters in type 2 diabetic patients with and without complications. PLoS ONE 15(8): e0237109. https://doi.org/10.1371/journal.pone.0237109.
14-Pelusi B, Gambineri A, Pasquali R. (2004). Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecol. 2004 Feb;56(1):41-51. PMID: 14973409.
15-Long C, Feng H, Duan W, Chen X, Zhao Y, Lan Y, Yue R. (2022). Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022 Aug 31;13:980405. doi: 10.3389/fendo.2022.980405. PMID: 36120432; PMCID: PMC9471325.
16-Mohanapu S, Jeyakumar A.M. (2019). Prevalence of glucose abnormalities in polycystic ovary syndrome women and evaluating the efficacy of fasting blood glucose in detecting these glucose abnormalities compared to glucose tolerance test. International Journal of Reproduction, Contraception, Obstetrics and GynecologyMohanapu S et al. Int J Reprod Contracept Obstet Gynecol. 2019 May;8(5):1751-1756www.ijrcog.org
17-Hsu MI. (2013). Changes in the PCOS phenotype with age. Steroids. 2013 Aug;78(8):761-6. doi: 10.1016/j.steroids.2013.04.005. Epub 2013 Apr 25. PMID: 23624031.
18-Falcetta, P., Benelli, E., Molinaro, A.. Di Cosmo C., Bagattini B., Del Ghianda S., Salvetti, G., Fiore, E., Pucci, E., Fruzzetti, F., Tonacchera, M. (2021). Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome. J Endocrinol Invest 44, 2725–2733 (2021). https://doi.org/10.1007/s40618-021-01594-5
19-Choudhary A., Jain S., Chaudhari P. (2017). Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?. International Journal of Reproduction, Contraception, Obstetrics and Gynecology Choudhary A et al. Int J Reprod Contracept Obstet Gynecol. 2017 Nov;6(11):4971-4975.
20-WHO (2023). Key facts of World Health Organization. Polycystic Ovary Syndrome. Accessed on 20th December, 2023 from https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary syndrome.
21-Deswal R, Narwal V, Dang A, Pundir CS. (2020). The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18. Epub 2020 Dec 28. PMID: 33627974; PMCID: PMC7879843.
© Duhok Medical Journal (DMJ), College of Medicine, University of Duhok, Iraq.
The contents of this journal, including articles, figures, and tables, are the intellectual property of their respective authors and the Duhok Medical Journal. Articles are published under a Creative Commons Attribution–NoDerivatives (CC BY-ND) license, permitting sharing and distribution with proper citation, provided that no modifications are made and the original work is properly credited.
Duhok Medical Journal (DMJ)
College of Medicine, University of Duhok
Duhok, Iraq
Email: [email protected]
